• Publications
  • Influence
Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline
Helena J Teede, Marie L Misso, Amanda A Deeks, Lisa J Moran, Bronwyn G A Stuckey, Jennifer L A Wong, Robert J Norman and Michael F Costello on behalf of the Guideline Development Groups
  • 271
  • 15
  • PDF
Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.
The new millennium has brought intense focus of interest on the risk of cardiovascular disease in women. The polycystic ovary syndrome (PCOS) is a common endocrine disorder in women characterised byExpand
  • 155
  • 13
Assessment of thyroid function during pregnancy: first‐trimester (weeks 9–13) reference intervals derived from Western Australian women
Objective: To establish first‐trimester‐specific reference intervals for thyroid function tests in pregnant Australian women.
  • 99
  • 10
  • PDF
Alendronate prevents loss of bone density associated with discontinuation of hormone replacement therapy: a randomized controlled trial.
BACKGROUND Many women using hormone replacement therapy (HRT) will discontinue HRT and lose its bone-protective effect. Methods to preserve bone density in these women need to be explored. ThisExpand
  • 70
  • 8
  • PDF
Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity
Postpartum thyroid dysfunction (PPTD), diagnosed using biochemical criteria, is usually transient with a wide range of reported prevalence rates. The specific clinical and psychiatric morbidityExpand
  • 84
  • 7
Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
BACKGROUND Polycystic ovary syndrome (PCOS) is associated with insulin resistance and features in common with the metabolic syndrome (MetS)--factors shown to predict cardiovascular risk and type 2Expand
  • 112
  • 7
Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
Both nonalcoholic fatty liver disease (NAFLD) and the polycystic ovary syndrome (PCOS) have a strong association with multiple cardiovascular risk factors. A number of studies have demonstrated aExpand
  • 42
  • 7
Management of menopausal symptoms in patients with breast cancer: an evidence-based approach.
Increasing numbers of women have menopausal symptoms after treatment for breast cancer. These symptoms can result directly from cancer treatments (such as oophorectomy, ovarian suppression,Expand
  • 83
  • 6
Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes
Genetic factors contribute strongly to sex hormone levels, yet knowledge of the regulatory mechanisms remains incomplete. Genome-wide association studies (GWAS) have identified only a small number ofExpand
  • 57
  • 6
  • PDF
Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary
T(4) is standard treatment for hypothyroidism. A recent study reported that combined T(4)/liothyronine (T(3)) treatment improved well-being and cognitive function compared with T(4) alone. WeExpand
  • 179
  • 5
  • PDF
...
1
2
3
4
5
...